You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AGMB Buy Disclosure
Epstein David R · SEC Form 4 · Filed Nov 6, 2026
Buy
Calculated transaction value
$34.55K
Epstein David R Director
AGMB
Transaction date
Nov 5, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 1 day later
AGMB daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common shares
- Quantity / price
- 5,000 shares @ $6.91
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001445826-26-000018
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$103.5K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Agomab Therapeutics Nv AGMB | Buy | Nov 5, 2026 | $34.05K |
| Agomab Therapeutics Nv AGMB | Buy | Nov 5, 2026 | $34.9K |
| Agomab Therapeutics Nv AGMB Current | Buy | Nov 5, 2026 | $34.55K |